GlassScriptPhysician profile
Aimee Grimm
NPI 1710416359
$3,488.92
in general payments reported to CMS, 2019-2025
17 companies · $499 in 2025
The $499 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $51.35 · 2021: $72.59 · 2022: $378 · 2023: $1,921 · 2024: $158 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616 · Travel and Lodging: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.21 |
| Travel and Lodging | $961.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,713.87 | 2019-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Sun Pharmaceutical Industries INC. | $776.09 | 2019-2025 | Cequa |
| Abbvie INC. | $238.52 | 2022-2025 | |
| Shire North American Group INC | $159.47 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $130.87 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $101.51 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $91.75 | 2019-2022 | |
| Optovue, INC. | $59.52 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $56.54 | 2019-2025 | Acuvue |
| Kala Pharmaceuticals, INC. | $41.55 | 2021-2022 | |
| Lkc Technologies, INC. | $23.50 | 2025 | |
| Harrow Eye, LLC | $22.92 | 2025 | Vevye |
| Eyevance Pharmaceuticals LLC | $16.02 | 2022 | |
| Bausch & Lomb Americas INC. | $14.77 | 2025 | Vyzulta |
| Oyster Point Pharma, INC. | $14.56 | 2025 | Tyrvaya |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $14.20 | 2019 | |
| Allergan, INC. | $13.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aimee Grimm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.